Initiator Pharma A/S
INIT
Rank in Stocks
#27086
Initiator Pharma A/S is a clinical-stage life sciences firm dedicated to... Initiator Pharma A/S is a clinical-stage life sciences firm dedicated to discovering therapeutic solutions for critical unmet medical needs affecting the central and peripheral nervous systems. Its development pipeline features several clinical-phase compounds: IP2018, a monoamine reuptake inhibitor aimed at psychogenic erectile dysfunction; IPED2015, designed to address organic erectile dysfunction; and IPTN2021, an orphan drug candidate for severe neuropathic pain. Additionally, the company holds early-stage assets, including IPNP2015 for chronic pain management and IPDP2015 for depression. Established in 2016, Initiator Pharma A/S maintains its headquarters in Copenhagen, Denmark.
Share Price
$0.24486274
Last synced: 2026-11-09
Market Cap
$16.76M
Change (1 day)
11.10%
Change (1 year)
-20.20%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Initiator Pharma A/S (INIT)
Category
Healthcare
P/B ratio for Initiator Pharma A/S (INIT)
P/B ratio as of November 2026 TTM: 10.66
According to Initiator Pharma A/S's latest financial reports and stock price, its current price-to-book ratio (TTM) is 10.66. At the end of 2025 the company had a P/B ratio of 4.31.
P/B ratio history for Initiator Pharma A/S from 2016 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| 2026 (TTM) | 10.66 | 147.30% |
| 2025 | 4.31 | 25,527.38% |
| 2024 | 0.02 | -99.94% |
| 2023 | 28.98 | 508,357.89% |
| 2022 | 0.01 | -3.39% |
| 2021 | 0.01 | -11.94% |
| 2020 | 0.01 | -51.45% |
| 2019 | 0.01 | 375.86% |
| 2018 | 0.00 | 26.09% |
| 2017 | 0.00 | -100.00% |
| 2016 | -113.56 | 0.00% |
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| 7.0081 | -34.25% |
US
|
|
| 12.9864 | 21.84% |
US
|
|
| 4.5726 | -57.10% |
AU
|
|
| 4.5877 | -56.96% |
BE
|
|
| 6.7286 | -36.87% |
NL
|
Questions about Initiator Pharma A/S's P/B ratio
What is Initiator Pharma A/S's P/B ratio?
Initiator Pharma A/S's P/B ratio is 10.66, as of Nov 2026.
What was Initiator Pharma A/S's P/B ratio in 2025?
In 2025, Initiator Pharma A/S's P/B ratio was 4.31, compared with 0.02 in 2024.
How has Initiator Pharma A/S's P/B ratio changed since 2020?
From 2020 to 2025, Initiator Pharma A/S's P/B ratio was highest in 2023 (28.98) and lowest in 2022 (0.01).
How does Initiator Pharma A/S's P/B ratio compare with similar companies?
Initiator Pharma A/S's P/B ratio (10.66) is higher than that of 4 of the 5 similar companies listed above. The highest among them is Moderna, Inc., with 12.99.